VRTX

Trade Vertex Pharmaceuticals Incorporated - VRTX stock price

1m
5m
15m
30m
1H
4H
1D
1W
History

VRTX

Vertex Pharmaceuticals Incorporated, a biotechnology company, develops medicines for serious diseases. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs. It markets ORKAMBI (lumacaftor in combination with ivacaftor) to treat patients with CF 12 years of age and older who are homozygous for the F508del mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene; KALYDECO (ivacaftor) for the treatment of patients with CF who have specific mutations in their CFTR gene, including the G551D mutation; and SYMDEKO (tezacaftor in combination with ivacaftor) to treat patients with CF 12 years of age and older who are F508del homozygous or who have 1 mutation that is responsive to tezacaftor/ivacaftor. The company also develops VX-659 and VX-445, which are CFTR corrector compounds in Phase II clinical trial; VX-150 that is in Phase II clinical trial to treat pain; VX-128, which is in Phase I clinical trial for the treatment of pain; CTX001, an investigational gene editing treatment that is in Phase I/II trial for the treatment of beta-thalassemia and sickle cell disease; pimodivir (JNJ-63623872), which is in a Phase III clinical development program to treat influenza; and VX-210 to treat acute spinal cord injury. It sells its products primarily to specialty pharmacy providers in North America, as well as government-owned and supported customers internationally. The company has collaborations with Cystic Fibrosis Foundation Therapeutics Incorporated; CRISPR Therapeutics AG; Moderna Therapeutics, Inc.; BioAxone Biosciences, Inc.; Parion Sciences, Inc.; Merck KGaA; Janssen Pharmaceuticals, Inc; and Q-State Biosciences, Inc. The company was founded in 1989 and is headquartered in Boston, Massachusetts.
White Paper Declaration
iPhone Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat
iMac Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat
iMac Image
1BTC
Invest
20BTC
Profit
Leverage:
x20
The Power Of Leverage
Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

VRTX price history

Date Close Change Change(%) Open High Low
Aug 15, 2022 305.18 11.66 3.97% 293.52 305.60 293.52
Aug 12, 2022 294.19 1.68 0.57% 292.51 295.38 291.82
Aug 11, 2022 292.00 -2.77 -0.94% 294.77 297.48 289.56
Aug 10, 2022 295.42 -5.59 -1.86% 301.01 301.14 294.91
Aug 9, 2022 298.63 4.56 1.55% 294.07 301.49 293.41
Aug 8, 2022 293.66 4.93 1.71% 288.73 296.64 288.52
Aug 5, 2022 287.83 15.15 5.56% 272.68 288.45 271.90
Aug 4, 2022 274.73 -2.14 -0.77% 276.87 277.78 272.70
Aug 3, 2022 274.79 -0.98 -0.36% 275.77 279.11 271.30
Aug 2, 2022 273.68 -1.32 -0.48% 275.00 278.00 272.80
Aug 1, 2022 273.65 -3.66 -1.32% 277.31 280.25 272.34
Jul 29, 2022 280.20 -1.31 -0.47% 281.51 281.96 275.40
Jul 28, 2022 280.63 -6.77 -2.36% 287.40 287.40 276.01
Jul 27, 2022 286.65 1.29 0.45% 285.36 287.81 280.37
Jul 26, 2022 287.93 4.11 1.45% 283.82 290.42 283.45
Jul 25, 2022 283.42 3.11 1.11% 280.31 283.60 278.55
Jul 22, 2022 280.08 -3.84 -1.35% 283.92 287.64 278.47
Jul 21, 2022 282.83 -2.71 -0.95% 285.54 286.28 280.82
Jul 20, 2022 285.32 -3.24 -1.12% 288.56 290.77 283.48
Jul 19, 2022 289.25 0.40 0.14% 288.85 289.86 285.80